{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:12:48Z","timestamp":1773681168155,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1124\/mol.106.027896","type":"journal-article","created":{"date-parts":[[2006,9,28]],"date-time":"2006-09-28T00:59:48Z","timestamp":1159405188000},"page":"19-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["In Vivo Responsiveness to Ezetimibe Correlates with Niemann-Pick C1 Like-1 (NPC1L1) Binding Affinity: Comparison of Multiple Species NPC1L1 Orthologs"],"prefix":"10.1016","volume":"71","author":[{"given":"Brian E.","family":"Hawes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim A.","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"Crona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Harry R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Graziano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott W.","family":"Altmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.106.027896_REF1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1388-1981(01)00190-1","article-title":"The identification of intestinal scavenger receptor class B, type I (SR-B1) by expression cloning and its role in cholesterol absorption","volume":"1580","author":"Altmann","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/mol.106.027896_REF2","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1126\/science.1093131","article-title":"Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption","volume":"303","author":"Altmann","year":"2004","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.106.027896_REF2a","doi-asserted-by":"crossref","unstructured":"Ballantyne CM (2002) Ezetimibe: efficacy and safety in clinical trials. Eur Heart J Suppl J9-J18.","DOI":"10.1016\/S1520-765X(02)90077-5"},{"key":"10.1124\/mol.106.027896_REF3","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1161\/01.CIR.0000068312.21969.C8","article-title":"Effect of ezetimibe coadministered with atorvostatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double blind trial","volume":"107","author":"Ballantyne","year":"2003","journal-title":"Circulation"},{"key":"10.1124\/mol.106.027896_REF4","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0149-2918(01)80102-8","article-title":"Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies","volume":"23","author":"Bays","year":"2001","journal-title":"Clin Ther"},{"key":"10.1124\/mol.106.027896_REF5","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.2174\/0929867043364865","article-title":"\u03b2-Lactam cholesterol absorption inhibitors","volume":"11","author":"Burnett","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1124\/mol.106.027896_REF6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0960-894X(01)00752-1","article-title":"Synthesis of fluorescent biochemical tools related to the 2-acetidinone class of cholesterol absorption inhibitors","volume":"12","author":"Burnett","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.106.027896_REF7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.277.5323.228","article-title":"Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis","volume":"277","author":"Carstea","year":"1997","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.106.027896_REF8","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1021\/jm960405n","article-title":"2-Azetidione cholesterol absorption inhibitors: structure-activity relationships on the heterocyclic nucleus","volume":"39","author":"Clader","year":"1996","journal-title":"J Med Chem"},{"key":"10.1124\/mol.106.027896_REF9","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0735-1097(02)02610-4","article-title":"Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia","volume":"40","author":"Davidson","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/mol.106.027896_REF10","first-page":"636","article-title":"Ezetimibe (SCH58235) inhibits cholesterol absorption, reduces plasma cholesterol, and inhibits the development of atherosclerosis in Apo E knockout mice fed a cholesterol-free diet (Abstract P3499)","volume":"21","author":"Davis","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1124\/mol.106.027896_REF11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0021-9150(00)80601-2","article-title":"The cholesterol inhibitor ezetimibe inhibits the development of atherosclerosis in apo E knockout (-\/-) mice fed lowfat and Western diets (Abstract TuP13 W16)","volume":"151","author":"Davis","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1124\/mol.106.027896_REF12","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/hq1201.100260","article-title":"Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice","volume":"21","author":"Davis","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/mol.106.027896_REF13","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1053\/meta.2001.26737","article-title":"The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in dogs","volume":"50","author":"Davis","year":"2001","journal-title":"Metabolism"},{"key":"10.1124\/mol.106.027896_REF14","doi-asserted-by":"crossref","first-page":"33586","DOI":"10.1074\/jbc.M405817200","article-title":"Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis","volume":"279","author":"Davis","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.106.027896_REF15","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0002-9149(02)02798-4","article-title":"Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia","volume":"90","author":"Dujovne","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1124\/mol.106.027896_REF16","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0002-9149(02)02774-1","article-title":"Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia","volume":"90","author":"Gagne","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1124\/mol.106.027896_REF17","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1073\/pnas.0500269102","article-title":"The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)","volume":"102","author":"Garcia-Calvo","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.106.027896_REF18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/bdd.405","article-title":"Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of 3-hydroxydesloratidine","volume":"25","author":"Ghosal","year":"2004","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/mol.106.027896_REF19","doi-asserted-by":"crossref","first-page":"17843","DOI":"10.1021\/bi982404y","article-title":"Identification of a receptor mediating absorption of dietary cholesterol in the intestine","volume":"37","author":"Hauser","year":"1998","journal-title":"Biochemistry"},{"key":"10.1124\/mol.106.027896_REF20","first-page":"382","article-title":"Characterization of the putative native and recombinant rat sterol transporter Niemann-Pick C1 Like 1 (NPC1L1) protein","volume":"1722","author":"Iyer","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/mol.106.027896_REF21","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/S0149-2918(03)80281-3","article-title":"Pharmacology and therapeutics of ezetimibe (SCH58235), a cholesterol absorption inhibitor","volume":"25","author":"Jeu","year":"2003","journal-title":"Clin Ther"},{"key":"10.1124\/mol.106.027896_REF22","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0002-9149(02)03236-8","article-title":"Efficacy and safety of exetimibe coadministered with lovastatin in primary hypercholesterolemia","volume":"91","author":"Kerzner","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1124\/mol.106.027896_REF23","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0195-668X(02)00807-2","article-title":"Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipid in patients with primary hypercholesterolemia","volume":"24","author":"Knopp","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1124\/mol.106.027896_REF24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0195-668X(02)00803-5","article-title":"Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial","volume":"24","author":"Melani","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1124\/mol.106.027896_REF25","first-page":"357","article-title":"TREEVIEW: An application to display phylogenetic trees on personal computers","volume":"12","author":"Page","year":"1996","journal-title":"Comput Appl Biosci"},{"key":"10.1124\/mol.106.027896_REF26","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/dmd.30.4.430","article-title":"Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects","volume":"30","author":"Patrick","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.106.027896_REF27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0021-9150(94)05499-9","article-title":"Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH48461","volume":"115","author":"Salisbury","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1124\/mol.106.027896_REF28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1096\/fasebj.9.9.7601339","article-title":"The family of G protein coupled receptors","volume":"9","author":"Strader","year":"1995","journal-title":"FASEB J"},{"key":"10.1124\/mol.106.027896_REF29","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1161\/01.CIR.0000034044.95911.DC","article-title":"Inhibition of intestinal cholesterol absorption by ezetimibe in humans","volume":"106","author":"Sudhop","year":"2002","journal-title":"Circulation"},{"key":"10.1124\/mol.106.027896_REF30","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","article-title":"Clustal W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice","volume":"22","author":"Thompson","year":"1994","journal-title":"Nucleic Acid Res"},{"key":"10.1124\/mol.106.027896_REF31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0960-894X(98)00008-0","article-title":"Sugar-substituted 2-azetidinone cholesterol absorption inhibitors: Enhanced potency by modification of the sugar","volume":"8","author":"Vaccaro","year":"1998","journal-title":"Biorg Med Chem"},{"key":"10.1124\/mol.106.027896_REF32","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.2337\/diabetes.50.6.1330","article-title":"Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters","volume":"50","author":"van Heek","year":"2001","journal-title":"Diabetes"},{"key":"10.1124\/mol.106.027896_REF33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-2999(01)00825-1","article-title":"The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys","volume":"415","author":"van Heek","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.106.027896_REF34","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1038\/sj.bjp.0703235","article-title":"Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663","volume":"129","author":"van Heek","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.106.027896_REF35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/sj.bjp.0704260","article-title":"Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function","volume":"134","author":"van Heek","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.106.027896_REF36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-3565(24)36992-7","article-title":"In vivo mechanism-based discovery of a potent cholesterol absorption inhibitor (SCH58235) through the identification of the active metabolites of SCH48461","volume":"283","author":"van Heek","year":"1997","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24042809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24042809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.106.027896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:40:12Z","timestamp":1739965212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24042809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0026895X24042809"],"URL":"https:\/\/doi.org\/10.1124\/mol.106.027896","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vivo Responsiveness to Ezetimibe Correlates with Niemann-Pick C1 Like-1 (NPC1L1) Binding Affinity: Comparison of Multiple Species NPC1L1 Orthologs","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.106.027896","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}